{"id":1562,"date":"2026-06-09T04:00:03","date_gmt":"2026-06-08T20:00:03","guid":{"rendered":"https:\/\/ab123.xyz\/?p=1562"},"modified":"2026-06-09T04:00:03","modified_gmt":"2026-06-08T20:00:03","slug":"%e5%85%a8%e7%90%83%e9%a6%96%e6%ac%be%e5%9f%ba%e5%9b%a0%e7%bc%96%e8%be%91%e7%96%97%e6%b3%95%e8%8e%b7fda%e6%89%b9%e5%87%86%e6%b2%bb%e7%96%97%e9%95%b0%e7%8a%b6%e7%bb%86%e8%83%9e%e7%97%85","status":"publish","type":"post","link":"https:\/\/ab123.xyz\/?p=1562","title":{"rendered":"\u5168\u7403\u9996\u6b3e\u57fa\u56e0\u7f16\u8f91\u7597\u6cd5\u83b7FDA\u6279\u51c6\u6cbb\u7597\u9570\u72b6\u7ec6\u80de\u75c5"},"content":{"rendered":"<p>\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u8fd1\u65e5\u6b63\u5f0f\u6279\u51c6\u4e86\u5168\u7403\u9996\u6b3e\u57fa\u4e8eCRISPR\u57fa\u56e0\u7f16\u8f91\u6280\u672f\u7684\u7597\u6cd5\uff0c\u7528\u4e8e\u6cbb\u7597\u9570\u72b6\u7ec6\u80de\u75c5\u3002\u8be5\u7597\u6cd5\u901a\u8fc7\u7f16\u8f91\u60a3\u8005\u81ea\u8eab\u7684\u9020\u8840\u5e72\u7ec6\u80de\uff0c\u4f7f\u5176\u4ea7\u751f\u6b63\u5e38\u8840\u7ea2\u86cb\u767d\uff0c\u4ece\u800c\u7f13\u89e3\u75bc\u75db\u548c\u8d2b\u8840\u75c7\u72b6\u3002\u4e34\u5e8a\u8bd5\u9a8c\u663e\u793a\uff0c\u8d85\u8fc790%\u7684\u60a3\u8005\u5728\u6cbb\u7597\u540e\u4e00\u5e74\u5185\u672a\u51fa\u73b0\u4e25\u91cd\u75bc\u75db\u5371\u673a\u3002\u8fd9\u9879\u7a81\u7834\u6027\u8fdb\u5c55\u6807\u5fd7\u7740\u57fa\u56e0\u6cbb\u7597\u4ece\u5b9e\u9a8c\u5ba4\u8d70\u5411\u4e34\u5e8a\u5e94\u7528\u8fc8\u51fa\u5173\u952e\u4e00\u6b65\uff0c\u4e3a\u6570\u767e\u4e07\u9057\u4f20\u75c5\u60a3\u8005\u5e26\u6765\u65b0\u5e0c\u671b\u3002<\/p>\n<p>\u6765\u6e90\uff1a<a href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/fda-approves-first-crispr-based-treatment-sickle-cell-disease-2023-12-08\/\" target=\"_blank\">\u8def\u900f\u793e\u62a5\u9053<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u8fd1\u65e5\u6b63\u5f0f\u6279\u51c6\u4e86\u5168\u7403\u9996\u6b3e\u57fa\u4e8eCRISPR\u57fa\u56e0\u7f16\u8f91\u6280\u672f\u7684\u7597\u6cd5\uff0c\u7528\u4e8e\u6cbb\u7597\u9570\u72b6\u7ec6\u80de\u75c5\u3002 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[2390,2392,2389,2391],"class_list":["post-1562","post","type-post","status-publish","format-standard","hentry","category-4","tag-fda","tag-2392","tag-2389","tag-2391"],"_links":{"self":[{"href":"https:\/\/ab123.xyz\/index.php?rest_route=\/wp\/v2\/posts\/1562","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ab123.xyz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ab123.xyz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ab123.xyz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ab123.xyz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1562"}],"version-history":[{"count":1,"href":"https:\/\/ab123.xyz\/index.php?rest_route=\/wp\/v2\/posts\/1562\/revisions"}],"predecessor-version":[{"id":1563,"href":"https:\/\/ab123.xyz\/index.php?rest_route=\/wp\/v2\/posts\/1562\/revisions\/1563"}],"wp:attachment":[{"href":"https:\/\/ab123.xyz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1562"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ab123.xyz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1562"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ab123.xyz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1562"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}